Jay was busy at JP Morgan. GenomeWeb have excellent coverage of all the big announcements; for me the most interesting is the information about Grail – the new liquid biopsy screening company and I covered that earlier today. In this post I thought I’d give […]
Illumina’s been busy in the cell-free DNA world, on the eve of JP Morgan Jay Flatley announced a new company, Grail, to screen cell free DNA for cancer. And at the end of last week Illumina ramped up litigation against companies using cfDNA for NIPT […]
Christmas came a little early to my lab with the delivery of two new HiSeq 4000 instruments. It would have been nice if these had come gift wrapped as it is the Christmas season, but alas no. Perhaps next year Illumina can get a little […]
PCR primers have become so cheap we had a discussion in the lab today about whether we should simply reorder, rather than try to find some old ones that weren’t where we thought they were! This rather glib suggestion made me think about how long […]
As part of the BBC’s 100 Women Season, they’ve been putting up some content that allows you to see how equally different countries treat men and women. One of these is the gender equality calculator and according to the Beeb “the UK is among the […]
Fancy being able to run 16 PCR programs simultaneously? The new MiniCube PCR machine from GNAcode does just that. Add qPCR functionality and this machine might improve NGS library prep.How does it work: The programmable nature the Minicube effectively gives you 16 different and independent […]
The Genomics Core is making space for some new equipment and so we’re clearing out some instruments we no longer use. If you are interested drop me a line…sale must end Friday December 4th. Little Dipper: Automates the washing and processing of Agilent and Illumina microarrays. […]
Me and therest of the Genomics Core team (past and present) put quite a bit of effort into communicating with our users. This ranges from simple communications about when a project will be complete, or a sample might be run; to more complex communications like […]
Cancer genomics is rapidly moving away from pure discovery to a much more translational perspective. An important area to consider, as the tools being used and developed in research labs are deployed to a more clinical setting, is an understanding of the reproducibility, sensitivity and […]
I’ve been doing some work looking at CRUKs cancer incidence statistics and this is what sparked the idea for this post. There are just under 350,000 new cancer cases in the UK each year. Although ctDNA can be found in many/most tumour contexts (Bettegowda et […]
